Reaction
Dry Gangrene reporting signals
As of the last recalculation, Dry Gangrene appears in 625 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 155.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canagliflozin | 114 | 155.0 | 155.6 |
| Norepinephrine Bitartrate | 49 | 122.9 | 123.3 |
| Norepinephrine | 32 | 105.0 | 105.3 |
| Ampicillin | 8 | 32.6 | 32.6 |
| Ampicillin Sodium | 8 | 32.6 | 32.6 |
| Heparin Sodium | 13 | 32.1 | 32.2 |
| Bosutinib | 7 | 26.2 | 26.3 |
| Adrenalinum | 27 | 22.6 | 22.6 |
| Gemcitabine | 23 | 20.1 | 20.2 |
| Ceftriaxone | 19 | 19.9 | 19.9 |
| Gemcitabine Hydrochloride | 25 | 16.3 | 16.3 |
| Sevelamer Carbonate | 5 | 14.6 | 14.6 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 4.3 | 4.3 |